Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Quant Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesReliance Industries Limited9.38038935026.2153
Domestic EquitiesAurobindo Pharma Limited9.224822350025.7807
Domestic EquitiesPoly Medicure Limited8.753714888224.4643
Domestic EquitiesLife Insurance Corporation Of India8.575824500023.9671
Domestic EquitiesGlaxosmithkline Pharmaceuticals Ltd7.914810600022.1196
Domestic EquitiesIndraprastha Medical Corporation Limited6.414267000017.9259
Domestic EquitiesJubilant Pharmova Limited6.031025000016.8550
Domestic EquitiesKovai Medical Center & Hospital Ltd.5.90013940016.4891
Domestic EquitiesGujarat Themis Biosyn Ltd4.774332500013.3429
Domestic EquitiesDishman Carbogen Amcis Ltd4.651856000013.0004
Domestic EquitiesSMS Pharmaceuticals Limited4.399960188612.2965
Domestic EquitiesSequent Scientific Limited4.287196896811.9813
Domestic EquitiesINDOCO REMEDIES LIMITED3.747132029510.4720
Domestic EquitiesSuven Life Sciences Ltd.3.28028300009.1674
Domestic EquitiesGranules India Limited3.18072100008.8893
Domestic EquitiesAarti Pharmalabs Limited2.95321608528.2533
Domestic EquitiesAstraZeneca Pharma India Ltd2.2187116226.2007
Domestic EquitiesBROOKS Laboratories Limited1.81344840545.0680
Domestic EquitiesKopran Limited1.40221500003.9188
Total 98.9032 276.4076
Cash & Cash Equivalents and Net AssetsTREPS 02-May-2024 DEPO 100.412311521.1522
Cash & Cash Equivalents and Net AssetsNCA-NET CURRENT ASSETS-1.1043 -3.0861
Total -0.6920 -1.9339
Treasury Bills91 Days Treasury Bill 02-May-20241.78885000004.9991
Total 1.7888 4.9991
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Awareness & Information | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.